Korea Ginseng Corp. said that a collaborative research team that it co-supports with Konyang University has found a potential mechanism in red ginseng polysaccharides that reduces cognitive decline in Alzheimer's disease.
The mechanism that red ginseng polysaccharides are related to synaptic and mitochondrial pathways in Alzheimer's disease was identified in this year’s research.
With an analysis of the protein-protein interaction of 111 proteins significantly changed by injecting red ginseng polysaccharide in mice, the research team found that the protein interaction decreased significantly.
Bioinformatics analysis confirmed that these proteins play an important role in nerve and synaptic development and function related to Alzheimer's disease, contributing to the preservation of mitochondrial forms.
How red ginseng polysaccharides do this was not fully clarified due to a lack of research two years ago.
"This study is meaningful because it has confirmed the possibility of red ginseng polysaccharides as candidates for effective treatments of Alzheimer's disease in animal models,” said Moon Min-ho, a professor at the College of Medicine at Konyang University.
In 2021, Konyang University’s Research Institute for Dementia Science, led by Professor Moon Min-ho, and Korea Ginseng Corporation's Research Institute team, led by Lee Yong-yook, announced in the international scientific journal Free Radical Biology and Medicine that red ginseng polysaccharide inhibits amyloid beta aggregation.
Alzheimer's occurs when amyloid beta, a proposed cause of Alzheimer's, aggregates and accumulates in the brain.


Netflix Nearing Major Deal to Acquire Warner Bros Discovery Assets
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
IMF Deputy Dan Katz Visits China as Key Economic Review Nears
Asian Currencies Steady as Rupee Hits Record Low Amid Fed Rate Cut Bets
ExxonMobil to Shut Older Singapore Steam Cracker Amid Global Petrochemical Downturn
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Dollar Holds Steady as Markets Shift Focus to 2026 Rate Cut Expectations
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Michael Dell Pledges $6.25 Billion to Boost Children’s Investment Accounts Under Trump Initiative
NASA Partners with Katalyst to Save Swift Observatory with Innovative Docking Mission
Wikipedia Pushes for AI Licensing Deals as Jimmy Wales Calls for Fair Compensation
Australia Moves Forward With Teen Social Media Ban as Platforms Begin Lockouts
Ancient Mars may have had a carbon cycle − a new study suggests the red planet may have once been warmer, wetter and more favorable for life
Asian Markets Mixed as Fed Rate Cut Bets Grow and Japan’s Nikkei Leads Gains
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
Tabletop particle accelerator could transform medicine and materials science 



